CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells
Bianca Pellegrino(Weizmann Institute of Science), Idit Shachar(Weizmann Institute of Science), Stav Rabani(Weizmann Institute of Science), Thuy Tran(Yale Cancer Center), Lin Leng(Yale University), Marta Piecychna(Yale Cancer Center), Keren David(Weizmann Institute of Science), Shirly Becker-Herman(Weizmann Institute of Science), Dov Hershkovitz(Tel Aviv Sourasky Medical Center), Roberto Meza‐Romero(Oregon Health & Science University), Richard Bucala(Yale University), Edward Doherty(Yale University), Bar Lampert(Weizmann Institute of Science), Arthur A. Vandenbark(Oregon Health & Science University)
Cited by 30
Related Papers
MIF Signal Transduction Initiated by Binding to CD74
|The Journal of Experimental Medicine|2003|1.1k
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
|The Lancet|2024|729
CD44 Is the Signaling Component of the Macrophage Migration Inhibitory Factor-CD74 Receptor Complex
|Immunity|2006|659
Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor.
|Proceedings of the National Academy of Sciences|1996|331